Our Privacy Statement & Cookie Policy

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

AstraZeneca in China: Innovation, Investment, and Commitment


CGTN anchor Zheng Junfeng interviewed AstraZeneca CEO Pascal Soriot, delving into the company's extensive strategic layout in China's pharmaceutical industry. From focusing on the domestic market to becoming a core base for global manufacturing and innovation, AstraZeneca has strengthened its business in China through significant investments in Wuxi and Qingdao, as well as a strong emphasis on research and development, contributing to the advancement of global health and economic growth. 

Search Trends